Skip to main content
NUTRITION 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Cellular and Physiological Nutrition/Metabolism

Clinical and Translational Nutrition

Session: Are We Ready? Resilience as a Biomarker for a “Healthy” Gut Microbiome

Panel Discussion - Are We Ready? Resilience as a Biomarker for a “Healthy” Gut Microbiome – an IAFNS-ASN Nutritional Microbiology GEM Collaboration

Monday, July 24, 2023
3:05 PM – 3:30 PM ET
Location:  Grand Ballroom

    Chair(s)

  • J. Philip Karl, PhD, RD

    Nutrition Physiologist
    U.S. Army Research Institute of Environmental Medicine
    Roslindale, Massachusetts, United States

    Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

    • Speaker(s)

  • CH

    Curtis Huttenhower, PhD (he/him/his)

    Professor
    Harvard T.H. Chan School of Public Health
    Boston, Massachusetts, United States

    Disclosure(s): Seres Therapeutics: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
    ZOE: Advisory Committee/Board Member (Ongoing)

  • AJ

    Abigail J. Johnson, PhD, RD

    Assistant Professor
    University of Minnesota
    Minneapolis, Minnesota, United States

    Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

  • Jotham Suez, PhD (he/him/his)

    Assistant Professor
    Johns Hopkins Bloomberg School of Public Health
    Baltimore, Maryland, United States

    Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Disclosure(s):
J. Philip Karl, PhD, RD: No relevant financial relationship(s) with ineligible companies to disclose.
Curtis Huttenhower, PhD: Seres Therapeutics: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
ZOE: Advisory Committee/Board Member (Ongoing)
Abigail J. Johnson, PhD, RD: No relevant financial relationship(s) with ineligible companies to disclose.
Jotham Suez, PhD: No relevant financial relationship(s) with ineligible companies to disclose.